Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

VYNE Therapeutics (VYNE) Times Interest Earned (2020 - 2021)

VYNE Therapeutics (VYNE) has disclosed Times Interest Earned for 2 consecutive years, with -$3.1 as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Times Interest Earned rose 85.59% year-over-year to -$3.1, compared with a TTM value of -$10.53 through Jun 2022, up 28.64%, and an annual FY2021 reading of -$6.94, up 87.94% over the prior year.
  • Times Interest Earned was -$3.1 for Q3 2021 at VYNE Therapeutics, up from -$8.88 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$3.1 in Q3 2021 and bottomed at -$156.24 in Q2 2020.